EMEA-001945-PIP01-16-M02

Key facts

Active substance
Avalglucosidase alfa
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0174/2020
PIP number
EMEA-001945-PIP01-16-M02
Pharmaceutical form(s)
Powder for concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of Pompe disease
Route(s) of administration
Intravenous use
Contact for public enquiries
Genzyme Europe B.V.

Tel. +31 2024 3917
E-mail: eumedinfo@genzyme.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating